3Sebag - Montefiore D, Stephens R J, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer ( MRC CR07 and NCIC - CTG C016) : a multicentre, random- ised trial [ J ]. Lancet, 2009, 373 (9666) : 811 -820.
4Chert CF, Huang MY, Huang C J, et al. A observational study of the efficacy and safety of capecitabine versus bolus infusional 5 - flu- omuracil in pre - operative chemoradiotherapy for locally advanced rectal cancer [ J]. Int J Colorectal Dis, 2012, 27 (6): 727-736.
5Hoiheinz RD, Wenz F, Post S, et al. Che- moradiotherapy with capecitabine versus flu- orouracil for locally advanced rectal cancer: arandomised, muhicentre, non - inferiority, phase 3 trial [J]. Lancet Oncol, 2012, 13 (6) : 579 -588.
6Sun PL, Li B, Ye QF. Effect of neoadjuvant cetuximab, capeeitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study [ J]. Int J Colorectal Dis, 2012. 27 C10) : 1325 - 1332.
7Rullier E, Goffre B, Bonnel C, et al. Pre- operative radiochemotherapy and sphincter- saving resection for T3 carcinomas of the lower third of the rectum [J]. Ann Surg, 2001, 234 (5) : 633 - 640.
8Tarantino I, Warschkow R, Worni M. Ele- vated preoperative CEA is associated with worse survival in stage I - 111 rectal cancer patients [ J ]. Br J Cancer, 2012, 107 (2) : 266 - 274.
9Kim CW, Yu CS, Yang SS, et al. Clinical significance of pre - to post - chemoradiother- apy s - CEA reduction ratio in rectal cancer patients treated with preoperative chemoradio- therapy and curative resection [ J ]. Ann Surg Oncol, 2011, 18 (12): 3271 - 3277.
10Chen CF,Huang MY,Huang CJ,et al. Aobservational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre- operative chemoradiotherapy for locally advanced rectal cancer [J].Int JColorectal Dis,2012,27(6):727-736.
